Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

SGHT Sight Sciences Inc

5,94

0,37 (6,64%)

Zuletzt aktualisiert: 20:24:20

Verzögert um 15 Minuten

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Sight Sciences (NASDAQ:SGHT)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Sight Sciences Charts.

Sight Sciences (NASDAQ:SGHT)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Sight Sciences Charts.

News Sight Sciences Inc

Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma
Dienstag 28 Mai 2024 (6 Stunden vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 21 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 17 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
Dienstag 7 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 6 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance
Donnerstag 2 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
Montag 29 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Sight Sciences to Report First Quarter Financial Results on May 2, 2024
Donnerstag 18 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2
Mittwoch 10 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Dienstag 2 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
Dienstag 26 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance
Donnerstag 7 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Sight Sciences Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen